Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
AIDS Care ; 31(4): 421-426, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30019914

RESUMO

Specific subsets of the adult population are at an increased risk of problem gambling behaviors. Previous research among these subsets has found increased rates of disordered gambling among those with drug use, alcohol use, mood, anxiety, and personality disorders. To what extent this may apply to the HIV population, known to have a high burden of co-occurring substance use and mental disorders, is not known The current study also examined the effectiveness of The Brief Biosocial Gambling Screen (BBGS) for the diagnosis of gambling disorder. This study examined the prevalence of gambling behaviors and disordered gambling in patients enrolled in an urban HIV clinic. 100 people living with HIV (PLWH) were assessed on gambling behaviors, impulsivity, and criterion on disordered gambling. Screening for gambling disorder using the BBGS was compared to the American Psychiatric Association DSM-5 criterion. The mean age was 53, 44% were female, 60% completed high school or above, and 80% self-identified as unemployed/disabled. 13% met four or more criteria for gambling disorder according to DSM-5 criteria. Participants that met criteria were more likely to report marijuana (p = .044) and heroin (p = .002) use, and greater impulsivity (p < 0.00001) when compared to participants who did not meet criteria. The BBGS was able to effectively screen individuals for disordered gambling with a sensitivity of 100%, specificity of 90.8%, positive predictive value of 56.2%, and a negative predictive value of 100%. These results suggest that urban HIV clinics may need to consider actively screening for gambling disorders, and referring to appropriate counseling and treatment for those who screen positive.


Assuntos
Comportamento Aditivo/epidemiologia , Jogo de Azar/epidemiologia , Infecções por HIV/psicologia , Comportamento Impulsivo , Adulto , Consumo de Bebidas Alcoólicas/epidemiologia , Baltimore/epidemiologia , Comportamento Aditivo/psicologia , Comorbidade , Manual Diagnóstico e Estatístico de Transtornos Mentais , Feminino , Jogo de Azar/psicologia , Infecções por HIV/epidemiologia , Humanos , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Prevalência , Transtornos Relacionados ao Uso de Substâncias/epidemiologia
2.
J Biomed Mater Res B Appl Biomater ; 106(5): 1662-1671, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-28842967

RESUMO

Hemorrhage is the leading cause of preventable death after a traumatic injury, and the largest contributor to loss of productive years of life. Hemostatic agents accelerate hemostasis and help control hemorrhage by concentrating coagulation factors, acting as procoagulants and/or interacting with erythrocytes and platelets. Hydrogel composites offer a platform for targeting both mechanical and biological hemostatic mechanisms. The goal of this work was to develop hydrogel particles composed of chitosan, alginate, and zeolite, and to assess their potential to promote blood coagulation via multiple mechanisms: erythrocyte adhesion, factor concentration, and the ability to serve as a mechanical barrier to blood loss. Several particle compositions were synthesized and characterized. Hydrogel bead composition was optimized to achieve the highest swelling capacity, greatest erythrocyte adhesion, and minimal in vitro cytotoxicity. These results suggest a polymer hydrogel-aluminosilicate composite material may serve as a platform for an effective hemostatic agent that incorporates multiple mechanisms of action. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1662-1671, 2018.


Assuntos
Alginatos , Coagulação Sanguínea/efeitos dos fármacos , Plaquetas/metabolismo , Quitosana , Eritrócitos/metabolismo , Hemostáticos , Zeolitas , Alginatos/química , Alginatos/farmacocinética , Alginatos/farmacologia , Animais , Plaquetas/patologia , Linhagem Celular , Quitosana/química , Quitosana/farmacocinética , Quitosana/farmacologia , Eritrócitos/patologia , Hemorragia/tratamento farmacológico , Hemorragia/metabolismo , Hemorragia/patologia , Hemostáticos/química , Hemostáticos/farmacocinética , Hemostáticos/farmacologia , Humanos , Camundongos , Zeolitas/química , Zeolitas/farmacocinética , Zeolitas/farmacologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa